Young age does not protect against the adverse effects of reduced ovarian reserve--an eight year study.
about
Poor ovarian reserveManagement of poor responders in IVF: is there anything new?Total fertilization failure: is it the end of the story?Evaluation of serum anti-Mullerian hormone as a biomarker of early ovarian aging in young women undergoing IVF/ICSI cycle.Live birth and cumulative live birth rates in expected poor ovarian responders defined by the Bologna criteria following IVF/ICSI treatment.Correlation of oocyte morphometry parameters with woman's age.Different ovarian response by age in an anti-Müllerian hormone-matched group undergoing in vitro fertilization.Fertility in female cancer survivors: pathophysiology, preservation and the role of ovarian reserve testing.Single and repeated GnRH agonist stimulation tests compared with basal markers of ovarian reserve in the prediction of outcome in IVF.Selective single blastocyst transfer reduces the multiple pregnancy rate and increases pregnancy rates: a pre- and postintervention study.Activin Decoy Receptor ActRIIB:Fc Lowers FSH and Therapeutically Restores Oocyte Yield, Prevents Oocyte Chromosome Misalignments and Spindle Aberrations, and Increases Fertility in Midlife Female SAMP8 Mice.Corifollitropin α followed by menotropin for poor ovarian responders' trial (COMPORT): a protocol of a multicentre randomised trial.Elevated basal FSH levels, if it is under 15 IU/L, will not reflect poor ART outcomes.Less is more: increased gonadotropin use for ovarian stimulation adversely influences clinical pregnancy and live birth after in vitro fertilizationAnti Mullerian Hormone: Ovarian response indicator in young patients receiving Long GnRH Agonist Protocol for Ovarian Stimulation.Elevated basal FSH and embryo quality: lessons from extended culture embryos: raised FSH and blastocyst quality.Assessment of ovarian reserve: Anti-Mullerian hormone versus follicle stimulating hormone.Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART).Does women's age influence zona pellucida birefringence of metaphase ΙΙ oocytes in in-vitro maturation program?In vitro fertilization outcome in women with diminished ovarian reserve.Is anti-Müllerian hormone associated with IVF outcomes in young patients with diminished ovarian reserve?Gonadotrophin-releasing hormone agonist protocol of controlled ovarian hyperstimulation as an efficient treatment in Bologna-defined poor ovarian responders.Comparison of age-related changes in anti-Müllerian hormone levels and other ovarian reserve tests between healthy fertile and infertile population.Are ART outcomes more successful in younger women? A retrospective study.Expected poor responders on the basis of an antral follicle count do not benefit from a higher starting dose of gonadotrophins in IVF treatment: a randomized controlled trial.Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist--gonadotropin treatment.Poor ovarian response in patients younger than 35 years: is it also a qualitative decline in ovarian function?Variation in the ovarian reserve is linked to alterations in intrafollicular estradiol production and ovarian biomarkers of follicular differentiation and oocyte quality in cattle.Antral follicle count reliably predicts number of morphologically healthy oocytes and follicles in ovaries of young adult cattle.Antral follicle count as a marker of ovarian biological age to reflect the background risk of fetal aneuploidy.Influence of BMI on risk of miscarriage after single blastocyst transfer.
P2860
Q26744379-C175C6FF-9831-4DB5-B64F-927E00A14B72Q34022512-0CC6713A-48A6-4FF4-8891-91AEE12960DBQ34145690-C6C637DA-BB27-4328-B30E-6E6973747E83Q34371743-0C8827F0-96D3-4513-8236-3DC66381F468Q35154524-34CC835E-238C-4DFC-9428-59E1D2D4F748Q35171093-11C9F283-8DE7-4153-BBDC-34CFE545A5F2Q35722615-7A92F1F6-DD85-4B35-A6BF-C3E2162AA68DQ35966481-18A5D63D-F507-4262-A5CE-64F61CADC0DCQ36270584-28AAB65F-5537-415D-B6A5-5E8F4320D000Q36477504-AC617526-E0EE-43CB-BA66-CA46C3655717Q36625099-4D921766-E9E5-49D2-B11A-7AE88C10D054Q36893583-A74856B6-9F48-4856-9AF6-F6DBBA33C6FCQ36970359-3D78FCF1-A914-4FC2-8AAF-32208CA15269Q37012942-2430F465-515F-4ACC-92B1-2C7B230D37F9Q37244112-B0193924-3383-4D1F-8BE2-2F44E676149CQ37313026-EF4C3D76-A5E3-494D-8E5C-4E23C28985AFQ37593698-0F7A4DBA-7A7C-4BDD-93DD-0A12D33708D8Q37606149-F4F10130-2283-4C7D-BD27-FFF818BE75AFQ37615365-CD42C28A-2D09-4A04-8AA9-3DD7B5D6271AQ37647328-89386B6C-DBEB-49FA-B8A9-5E1D3553349FQ37732167-8CD7F04F-FA06-4F0B-B1E6-CC417C531BE3Q39825272-274F0E39-ECEB-45FA-86E2-4546AD1584F9Q42497324-7B202AE7-62F5-4345-AC7D-0BDAD5E676D5Q43561152-03C3625F-3607-40FA-B448-A5C9D138DECFQ45182687-9484C94F-D180-497C-9CC1-C64FBA9D76CDQ45234419-E92C66DA-1FB5-4E6D-AC2F-D894E11DE7A4Q45959530-38CECB62-4C42-4766-90EF-2F63A341C81DQ46151084-5DB8150D-DF34-40B8-B9FE-31B13F247C85Q46392000-B49A57EC-A90C-4521-9A66-BE303DDDADB7Q48605261-29AF2020-9F9C-4ABF-ADD0-09AB1EE038C9Q51430201-C6C4A006-B7B3-4879-8F8E-169F6B3172EA
P2860
Young age does not protect against the adverse effects of reduced ovarian reserve--an eight year study.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Young age does not protect aga ...... reserve--an eight year study.
@en
Young age does not protect aga ...... reserve--an eight year study.
@nl
type
label
Young age does not protect aga ...... reserve--an eight year study.
@en
Young age does not protect aga ...... reserve--an eight year study.
@nl
prefLabel
Young age does not protect aga ...... reserve--an eight year study.
@en
Young age does not protect aga ...... reserve--an eight year study.
@nl
P2093
P2860
P356
P1433
P1476
Young age does not protect aga ...... reserve--an eight year study.
@en
P2093
Alison Taylor
Peter Braude
Roger Hart
Tarek El-Toukhy
Yacoub Khalaf
P2860
P304
P356
10.1093/HUMREP/17.6.1519
P407
P577
2002-06-01T00:00:00Z